Inlighta Biosciences L.L.C.
Marietta, GA Doing business as Inlighta Biosciences LLC
- UEI
- KCSBM7ASMA34
- CAGE
- 6PX44
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 5075 Lake Fjord Pass, Marietta, GA 30068, USA
- Website
- inlighta.com
- Founded
- 2012
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Design of calcium-sensing receptor targeted thera(g)nostic agents - summary calcium-sensing receptor (casr), as one of… | National Institute of Diabetes and Digestive and Kidney Diseases | $647,486 | |
| Precision MRI with protein contrast agent for noninvasive detection of lung fibrosis - summary lung diseases, such as… | National Heart Lung and Blood Institute | $1,026,874 | |
| Precision MRI with a novel protein contrast agent for early detection and staging of lung fibrosis - summary lung… | National Heart Lung and Blood Institute | $597,680 | |
| Non-invasive staging of metastasis by precision MRI - project summary/abstract this sbir application will develop an… | National Cancer Institute | $3,908,443 | |
| Development of a novel MRI contrast agent for early detection of alcoholic steatohepatitis | National Institute on Alcohol Abuse and Alcoholism | $3,303,618 |
About Inlighta Biosciences L.L.C.
Inlighta Biosciences L.L.C. is a woman-owned small business located in Marietta, Georgia, registered in the System for Award Management (SAM) since 2012. The company operates as a for-profit limited liability company focused on developing advanced medical research technologies, particularly in the realm of precision imaging and diagnostic agents. While specific details about the company's full commercial profile are not provided, the federal grant awards suggest a strong emphasis on developing innovative medical diagnostic and therapeutic technologies utilizing protein-based contrast agents and targeted molecular approaches.
The company has secured multiple significant federal grant awards from prestigious National Institutes of Health (NIH) institutes, including the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Heart Lung and Blood Institute, National Cancer Institute, and National Institute on Alcohol Abuse and Alcoholism. These grants have supported research into developing novel MRI contrast agents and targeted therapeutic approaches for various medical conditions. Specific research projects include designing calcium-sensing receptor (CaSR) targeted theragnostic agents for polycystic kidney disease, developing precision MRI protein contrast agents for early detection of lung fibrosis, creating non-invasive staging technologies for pancreatic cancer liver metastasis, and developing MRI contrast agents for detecting alcoholic steatohepatitis. The grants range from $647,486 to support CaSR research to projects aimed at creating innovative medical imaging technologies that can potentially improve early disease detection and staging across multiple medical domains.
Quick answers
What is Inlighta Biosciences L.L.C.'s UEI?
Inlighta Biosciences L.L.C.'s Unique Entity ID (UEI) in SAM.gov is KCSBM7ASMA34.
What is Inlighta Biosciences L.L.C.'s CAGE code?
Inlighta Biosciences L.L.C.'s CAGE code is 6PX44.
What is Inlighta Biosciences L.L.C.'s primary NAICS code?
Inlighta Biosciences L.L.C.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Inlighta Biosciences L.L.C. located?
Inlighta Biosciences L.L.C.'s physical address in SAM.gov is 5075 Lake Fjord Pass, Marietta, GA 30068, USA.
Is Inlighta Biosciences L.L.C. registered in SAM.gov?
Yes. Inlighta Biosciences L.L.C.'s SAM.gov registration is active through August 25, 2027.
What is Inlighta Biosciences L.L.C.'s most recent federal award?
Inlighta Biosciences L.L.C.'s most recent federal grant award is Design of calcium-sensing receptor targeted thera(g)nostic agents - summary calcium-sensing receptor (casr), as one of… (R41DK139927), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 1, 2024.
On GovTribe
See Inlighta Biosciences L.L.C.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors